Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Depressive Disorder, Major
Interventions
DRUG

vortioxetine (Lu AA21004)

Lu AA21004 capsules

DRUG

Duloxetine

Duloxetine capsules

DRUG

Placebo

Placebo matching capsules

Trial Locations (92)

Unknown

Tucson

Little Rock

Bellflower

Carson

Cerritos

Glendale

Imperial

Los Angeles

Norwalk

Oakland

Paramount

San Bernardino

Santa Ana

Wildomar

Colorado Springs

Denver

Norwalk

Lauderhill

Miami

Orlando

Sanford

St. Petersburg

Tampa

West Palm Beach

Chicago

Hoffman Estates

Naperville

Oak Brook

Skokie

Indianapolis

Prairie Village

Shreveport

Baltimore

Haverhill

St Louis

North Platte

Las Vegas

Buffalo

New York

Staten Island

Avon Lake

Beachwood

Garfield Heights

Toledo

Oklahoma City

Portland

Allentown

Norristown

Philadelphia

Columbia

Franklin

Memphis

Dallas

Houston

San Antonio

The Woodlands

Orem

Salt Lake City

Kirkland

Seattle

Brown Deer

Milwaukee

Kazanlak

Novi Iskar

Pleven

Plovdiv

Sofia

Tzerova Koria

Helsinki

Kuopio

Turku

Berlin

Bochum

Chemnitz

Hanover

München

Schwerin

Westerstede

Wiesbaden

Bialystok

Leszno

Lodz

Torun

Nizhny Novgorod

Saint Petersburg

Smolensk

Stavropol

Yekaterinburg

Kharkiv

Kyiv

Luhansk

Ternopil

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY